We hereby submit Audited Financial Results for Q4 & FY2026.
YATHARTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Yatharth Hospital reported strong FY2026 results with standalone revenue growing 30% to ₹5,919 million and consolidated revenue up 36% to ₹12,072 million. Consolidated profit after tax jumped 30% to ₹1,703 million, translating to EPS of ₹18.20 versus ₹14.72 in FY2025. The company expanded its hospital network during the year—acquiring a 300-bed facility in Delhi's Model Town (operational from July 2025), a 400-bed hospital in Faridabad (September 2025), and a 150-bed Shantived hospital in Agra (February 2026). Finance costs surged significantly (standalone: ₹57 million vs ₹6 million last year) due to increased borrowings for acquisitions. The statutory auditor MSKA & Associates issued an unmodified opinion, and no going concern or qualified opinion issues were raised.
The results demonstrate robust growth driven by network expansion and acquisitions, though the sharp increase in finance costs warrants monitoring. The stock's EPS improvement and strong revenue trajectory are positive signals for shareholders, but rising debt levels to fund acquisitions may concern some investors.